Know Cancer

or
forgot password

Screening and Identification of Novel Diagnostic and Prognostic Biomarkers on Endometrial Cancers


N/A
15 Years
80 Years
Open (Enrolling)
Female
Endometrial Cancers

Thank you

Trial Information

Screening and Identification of Novel Diagnostic and Prognostic Biomarkers on Endometrial Cancers


Inclusion Criteria:



- Patients with endometrial cancers who undergo hysterectomy, bilateral
salpingo-oophorectomy, omentectomy, and appendectomy will be enrolled and the
clinical data will be obtained from our hospital. All of the patients received four
to six courses of adjuvant platinum-containing chemotherapy.Histologic grading was
according to International Union against Cancer criteria (28). The stage of disease
was classified according to the International Federation of Gynecology and Obstetrics
(FIGO, 1987). Pelvic and paraaortic lymph node samplings will be performed, if the
disease will be confined to within the ovary or will be without a ruptured capsule.
The histopathologic data, including histologic type and histologic grade, will be
evaluated by a certified pathologist. The maximal diameter of the residual tumor
after surgery will be also recorded. All patients will be followed up at 3-month
intervals.

Type of Study:

Interventional

Study Design:

Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science

Outcome Measure:

overall survival

Outcome Time Frame:

from disease diagnosis to death

Safety Issue:

No

Authority:

Taiwan: Department of Health

Study ID:

200706001R

NCT ID:

NCT00674349

Start Date:

January 2006

Completion Date:

December 2011

Related Keywords:

  • Endometrial Cancers
  • Endometrial Neoplasms
  • Sarcoma, Endometrial Stromal
  • Adenoma

Name

Location